Synthesis of CMI-977, a Potent 5-Lipoxygenase Inhibitor. -A facile large-scale synthesis of the potent 5-lipoxygenase inhibitor CMI-977 (XI) in enantiomerically pure form starting from hydroxymethyl-γ-butyrolactone (I) derived from (S)-glutamic acid is described (yields given in g). -(CAI,
Synthesis of CMI-977, a Potent 5-Lipoxygenase Inhibitor †
✍ Scribed by Cai, Xiong; Chorghade, Mukund S.; Fura, Aberra; Grewal, Gurmit S.; Jauregui, Karen A.; Lounsbury, Heather A.; Scannell, Ralph T.; Yeh, C. Grace; Young, Michelle A.; Yu, Shaoxia; Guo, Liang; Moriarty, Robert M.; Penmasta, Raju; Rao, Munagala S.; Singhal, Rajesh K.; Song, Zhengzhe; Staszewski, James P.; Tuladhar, Sudersan M.; Yang, Sanmin
- Book ID
- 121361703
- Publisher
- American Chemical Society
- Year
- 1999
- Tongue
- English
- Weight
- 103 KB
- Volume
- 3
- Category
- Article
- ISSN
- 1083-6160
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
-propoxy-S(N'-butyl-N'-hydroxyureidyl)phenyl]-S-(3,4.5-trimethoxyphenyl)tetrahydrofuran, was synthesized and was found to antagonize PAP receptor binding and inhibit S-lipoxygenase activity both in vitro and in vivo.
A practical gram scale asymmetric synthesis of CMI-977 is described. A tandem double elimination of an a-chlorooxirane and concomitant intramolecular nucleophilic substitution was used as the key step. Jacobsen hydrolytic kinetic resolution and Sharpless asymmetric epoxidation protocols were applied